Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury

Abstract excerpt

Acute kidney injury (AKI), a sudden loss of kidney function, is a common and serious condition for which there are no approved specific therapies. While there are multiple approaches to treat the underlying causes of AKI, no targets have been clinically validated. Here, we assessed a series of potent, selective competitive inhibitors of histone deacetylase 8 (HDAC8), a promising therapeutic target in an AKI...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Kidney Injury Research
• Share to Histone Deacetylase Inhibitors Research
• Share to Renal Transplantation Outcomes and Treatments